Cargando…
Early changes of fecal short‐chain fatty acid levels in patients with mild cognitive impairments
AIMS: To compare the fecal levels of short‐chain fatty acids (SCFAs) in patients with mild cognitive impairment (MCI) and normal controls (NCs) and to examine whether fecal SCFAs could be used as the biomarker for the identification of patients with MCI. To examine the relationship between fecal SCF...
Autores principales: | Gao, Chao, Li, Binyin, He, Yixi, Huang, Pai, Du, Juanjuan, He, Guiying, Zhang, Pingchen, Tang, Huidong, Chen, Shengdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580335/ https://www.ncbi.nlm.nih.gov/pubmed/37144597 http://dx.doi.org/10.1111/cns.14252 |
Ejemplares similares
-
Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson’s disease
por: Huang, Pei, et al.
Publicado: (2023) -
Fecal and Blood Microbial 16s rRNA Gene Alterations in Chinese Patients with Multiple System Atrophy and Its Subtypes
por: Du, Juanjuan, et al.
Publicado: (2019) -
Specific gut microbiota alterations in essential tremor and its difference from Parkinson’s disease
por: Zhang, Pingchen, et al.
Publicado: (2022) -
Gut Microbiota: Implications in Alzheimer’s Disease
por: He, Yixi, et al.
Publicado: (2020) -
The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
por: Liu, Jin, et al.
Publicado: (2020)